Ausdal Financial Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10,490
| Closed | -$84K | – | 519 |
|
|
2021
Q4 | $84K | Sell |
10,490
-2,220
| -17% | -$17.8K | 0.01% | 467 |
|
|
2021
Q3 | $124K | Sell |
12,710
-4,908
| -28% | -$47.9K | 0.02% | 454 |
|
|
2021
Q2 | $174K | Hold |
17,618
| – | – | 0.03% | 442 |
|
|
2021
Q1 | $203K | Sell |
17,618
-7,730
| -30% | -$89.1K | 0.03% | 414 |
|
|
2020
Q4 | $130K | Buy |
25,348
+1,950
| +8% | +$10K | 0.03% | 402 |
|
|
2020
Q3 | $107K | Buy |
23,398
+11,920
| +104% | +$54.5K | 0.03% | 337 |
|
|
2020
Q2 | $142K | Buy |
+11,478
| New | +$142K | 0.05% | 272 |
|
|
2019
Q4 | – | Sell |
-15,653
| Closed | -$108K | – | 340 |
|
|
2019
Q3 | $108K | Buy |
15,653
+4,700
| +43% | +$32.4K | 0.04% | 297 |
|
|
2019
Q2 | $87K | Sell |
10,953
-150
| -1% | -$1.19K | 0.03% | 282 |
|
|
2019
Q1 | $174K | Sell |
11,103
-79
| -0.7% | -$1.24K | 0.07% | 257 |
|
|
2018
Q4 | $172K | Sell |
11,182
-5,550
| -33% | -$85.4K | 0.08% | 228 |
|
|
2018
Q3 | $360K | Buy |
16,732
+1,090
| +7% | +$23.5K | 0.1% | 244 |
|
|
2018
Q2 | $380K | Hold |
15,642
| – | – | 0.12% | 233 |
|
|
2018
Q1 | $267K | Buy |
+15,642
| New | +$267K | 0.09% | 274 |
|
|
2017
Q4 | – | Sell |
-12,466
| Closed | -$219K | – | 369 |
|
|
2017
Q3 | $219K | Buy |
12,466
+3,141
| +34% | +$55.2K | 0.09% | 295 |
|
|
2017
Q2 | $310K | Buy |
9,325
+2,700
| +41% | +$89.8K | 0.13% | 213 |
|
|
2017
Q1 | $213K | Buy |
+6,625
| New | +$213K | 0.1% | 254 |
|
|
2016
Q1 | – | Sell |
-700
| Closed | -$46K | – | 932 |
|
|
2015
Q4 | $46K | Buy |
+700
| New | +$46K | 0.02% | 481 |
|